GP2013 in the Treatment of Patients With Previously Untreated, Advanced Stage Follicular Lymphoma (ASSIST_FL)

PHASE3CompletedINTERVENTIONAL
Enrollment

629

Participants

Timeline

Start Date

December 1, 2011

Primary Completion Date

July 10, 2015

Study Completion Date

January 22, 2018

Conditions
Follicular Lymphoma
Interventions
BIOLOGICAL

GP2013

Type: Biological/Vaccine

BIOLOGICAL

rituximab

Type: Biological/Vaccine

Trial Locations (153)

Unknown

Investigative site, La Plata

Investigative site, Rosario

Investigative site, San Miguel de Tucumán

Investigative site, Adelaide

Investigative site, Ballarat

Investigative site, Epping

Investigative site, Footscray

Investigative site, Wodonga

Investigative site, Graz

Investigative site, Vienna

Investigative site, Barretos

Investigator site, Barretos

Investigative site, Botucatu

Investigative site, Campinas

Investigative site, Curitiba

Investigative site, Florianópolis

Investigative site, Fortaleza

Investigative site, Goiânia

Investigative site, Jaú

Investigative site, Passo Fundo

Investigative site, Porto Alegre

Investigative Site, Rio de Janeiro

Investigative site, Santo André

Investigative site, São Paulo

Investigative site, Sorocaba

Investigative site, Pleven

Investigative site, Plovdiv

Investigative site, Rousse

Investigative site, Sofia

Investigative site, Varna

Investigative site, Medellín

Investigative site, Montería

Investigative site, Colmar

Investigative site, Nîmes

Investigative site, Strasbourg

Investigative site, Bad Saarow

Investigative site, Koblenz

Investigative site, Athens

Investigative site, Ioannina

Investigative site, Larissa

Investigative site, Pátrai

Investigative site, Győr

Investigative site, Kaposvár

Investigative site, Ahmedabad

India, Amritsar

Investigative site, Aurangabad

Investigative site, Bangalore

Investigative site, Chennai

Investigative site, Hyderabad

Investigative site, Kolkata

Investigtive site, Kolkata

Investigative site, Madurai

Investigative site, Mumbai

Investigative site, Nashik

Investigative site, New Delhi

Investigative site, Pune

Investigative site, Surat

Investigative site, Trivandrum

Investigative site, Vellore

Investigative site, Dublin

Investigative site, Limerick

Investigative site, Waterford

Investigative site, Ashkelon

Investigative site, Nahariya

Investigative site, Bari

Investigative site, Florence

Investigative site, Meldola

Investigative site, Milan

Investigative site, Palermo

Investigative site, Pavia

Investigative site, Pescara

Investigative site, Piacenza

Investigative site, Ravenna

Investigative site, Reggio Calabria

Investigative site, Varese

Investigative site, Aomori

Investigative site, Fukuoka

Investigative site, Gifu

Investigative site, Kagoshima

Investigative site, Kitakyushu

Investigative site, Kobe

Investigative site, Komaki

Investigative site, Matsuyama

Investigative site, Okayama

Investigative site, Ōgaki

Invstigative site, Ōmura

Investigative site, Ōtake

Investigative site, Saga

Investigative site, Tachikawa

Investigative site, Alor Star

Investigative site, Ampang

Investigative site, George Town

Investigative site, Ipoh

Investigative site, Johor Bahru

Investigative site, Klang

Investigative site, Kuala Lumpur

Investigative site, Kuching

Investigative site, Malacca

Investigative site, Pulau Pinang

Investigative site, Subang Jaya

Investigative site, Amsterdam

Investigative site, Delft

Investigative site, Gouda

Investigative site, Heerlen

Investigative site, Rotterdam

Investigative site, Schiedam

Investigative site, Sittard

Investigative site, Zwolle

Investigative site, Lima

Investigative site, Brzozów

Investigative site, Bydgoszcz

Investigative site, Chorzów

Investigative site, Krakow

Investigative site, Lublin

Investigative site, Warsaw

Investigative site, Braga

Investigative site, Coimbra

Investigative site, Lisbon

Investigative site, Porto

Investigative site, Brasov

Investigative site, Bucharest

Investigative site, Cluj-Napoca

Investigative site, Iași

Investigative site, Timișoara

Investigative site, Arkhangelsk

Investigative site, Chelyabinsk

Investigative site, Krasnodar

Investigative site, Kursk

Investigative site, Moscow

Investigative site, Nizhny Novgorod

Investigative site, Rostov-on-Don

Investigative site, Saint Petersburg

Investigative site, Cape Town

Investigative site, George

Investigative site, Johannesburg

Investigative site, Port Elizabeth

Investigative site, Pretoria

Investigative site, Barcelona

Investigative site, Donostia / San Sebastian

Investigative site, Madrid

Investigative site, Oviedo

Investigative site, Seville

Investigative site, Zaragoza

Investigative site, Cherkasy

Investigative site, Dnipropetrovsk

Investigative site, Donetsk

Investigative site, Ivano-Frankivsk

Investigative site, Kharkiv

Investigative site, Kyiv

Investigative site, Lviv

Investigative site, Eastbourne

Investigative site, London

Investigative site, Worthing

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

Sandoz

INDUSTRY